Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
SWEDISH ORPHAN BIOVITRUM
🇫🇷
France
Country
🇫🇷
France
Ownership
-
Established
2010-01-01
Employees
-
Market Cap
$10.7B
Website
http://www.sobi.com/
Clinical Trials
Related News
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support
Phase 1
Completed
Conditions
Lymphoma
Leukemia
Myeloma
Interventions
Drug: Palifermin 2 x 180 μg/kg/day
Drug: Palifermin 6 x 60 μg/kg/day
Radiation: radiotherapy
Drug: Chemotherapy
Subscribe
First Posted Date
2003-10-08
Last Posted Date
2014-10-24
Lead Sponsor
Swedish Orphan Biovitrum
Target Recruit Count
25
Registration Number
NCT00070616
Subscribe
Prev
1
4
5
6
7
8
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy